Skip to content

Early Vision Screening in High-risk Children

Early Vision Screening With Automated Photorefraction in Pre-term, Low-birth- Weight and Development-delay Children in Far-Eastern Memorial Hospital, Taiwan

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02678468
Enrollment
200
Registered
2016-02-09
Start date
2016-02-29
Completion date
2018-03-31
Last updated
2017-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia, Child

Brief summary

To evaluate the effect of early vision screening with automated photorefraction device in high risk children

Detailed description

Pre-term, low-birth-weight, and development delay are well-known risk factors related to higher incidence of high refractive error and strabismus, which can potentially lead to amblyopia and is regarded as amblyopia risk factors. This project is a cross-sectional controlled study. Our study includes high-risk group and normal group. High-risk group includes children with birth history of pre-term, low-birth-weight and the diagnosis of development delay in FEMH. Normal group enrolled age-matched children without those risk factors. Vision screening by FDA-approved photorefraction device as well as comprehensive ophthalmic exams for definite diagnosis will be performed on the high-risk group and the normal group.

Interventions

None listed

Sponsors

Far Eastern Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
1 Years to 2 Years
Healthy volunteers
Yes

Inclusion criteria

* High risk group: children with gestational age less than 36weeks, birth weight less than 2500g and children diagnosed as develop delay * Normal group: children with normal birth history and normal development

Exclusion criteria

* Children with known ophthalmic diseases * Children with congenital systemic diseases

Design outcomes

Primary

MeasureTime frameDescription
positive predictive value of vision screeningone yearpositive predictive value

Secondary

MeasureTime frameDescription
Odds ratio of having amblyopia risk factorsone yearOdds ratio

Countries

Taiwan

Contacts

Primary ContactYao-Lin Liu, M.D.
liuyaolin.tw@gmail.com886-289667000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026